Il Dong Pharmaceutical Q3 Net Income Falls 86.6% Year on Year

PUBT · 1d ago
Il Dong Pharmaceutical Q3 Net Income Falls 86.6% Year on Year
  • Il Dong Pharmaceutical’s third-quarter 2026 net profit fell 86.6% year over year to 3.99 billion won.
  • Operating profit declined 19.4% to 7.74 billion won.
  • Revenue rose 4.6% to 150.55 billion won.
  • For January–September 2026, operating profit increased 29.7% to 24.3 billion won.
  • Net profit for the nine-month period dropped 64.4% to 11.76 billion won.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Il Dong Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261102800778), on November 02, 2026, and is solely responsible for the information contained therein.